1458694-01-3Relevant articles and documents
Novel 1-(1-benzyl-1H-indol-3-yl)-N,N,N-trimethylmethanaminium iodides are competitive antagonists for the human α4β2 and α7 nicotinic acetylcholine receptors
Perez, Edwin G.,Ocampo, Cristian,Feuerbach, Dominik,Lopez, Jhon J.,Morelo, Guibeth L.,Tapia, Ricardo A.,Arias, Hugo R.
, p. 1166 - 1170 (2013)
This work presents the synthesis and the pharmacological characterization of a series of novel 1-(1-benzyl-1H-indol-3-yl)-N,N,N-trimethylmethanaminium iodide derivatives at the human (h) α7 and α4β2 nicotinic acetylcholine receptors (nAChRs). The inhibito